Robotic-assisted surgeries, led by da Vinci Surgical System, are expanding rapidly, improving efficiency, outcomes, and competition while driving adoption, innovation, and investment across modern healthcare systems.

Monitoring cerebral oxygenation in extremely preterm infants enables early intervention to prevent brain injury, improve survival, guide NICU care, and support better long-term neurodevelopmental outcomes.

Digital tools, wearables, and AI extend therapy beyond sessions, enabling real-time support, earlier intervention, and personalized care, while requiring updated reimbursement models, privacy safeguards, and clinician workflows.

Fetal Alcohol Spectrum Disorder is a lifelong neurodevelopmental condition caused by prenatal alcohol exposure, leading to cognitive, behavioral, and mental health challenges requiring early diagnosis, coordinated care, and support.

Narcolepsy often coexists with psychiatric, respiratory, and metabolic conditions, complicating diagnosis and treatment, requiring comprehensive, multidisciplinary care to improve safety, functioning, and long-term patient outcomes.

The 2026 American Academy of Neurology Annual Meeting 2026 highlights neurology’s shift toward biomarker-driven diagnosis, personalized care, emerging therapies, and ongoing challenges in access, cost, and real-world implementation.

AAN 2026 highlights transformative ADAPT data, expanding Vyvgart across MG subtypes and CIDP, signaling targeted biologics, pediatric advances, and urgent updates to managed care coverage frameworks.

Post hoc ADHERE analysis shows Vyvgart Hytrulo delivers early responses in 87.5% of treatment-naive CIDP patients, challenging step-therapy policies and prompting reconsideration of first-line treatment strategies.

At AAN Annual Meeting 2026, efgartigimod alfa showed durable adolescent gMG responses, with 80% achieving minimal symptom expression by cycle two and consistent improvements across treatment cycles.

Pixee Medical’s Knee+ NexSight gains U.S. Food and Drug Administration 510(k) clearance, bringing lightweight AR-guided knee replacement to U.S. operating rooms, aiming to improve precision, efficiency, and outpatient surgical access.